Public Market Listing
0950HKEX
Live quotes, historical charts, and market capitalization for Lee's Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
1Phase 3 / Filed
3Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Loxapine (Adasuve)No recent activity | Phase 3 | Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule | SchizophreniaBipolar Disorder |
| Phase 2/3 | Na-K ATPase / SERCA2aSmall molecule | Heart Failure Cardiogenic Shock in Acute Heart Failure | |
rostafuroxinNo recent activity | Phase 2 | Endogenous ouabain / mutant adducinSmall molecule | Hypertension Resistant Hypertension with Adducin/Ouabain Polymorphisms |
| Preclinical / Unstaged | L-type calcium channels (Cav1.2)Small molecule | Hypertension |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2028 (1)
December 2028 (1)
Est. primary completion 2028-12 · NCT07583446 · CT.gov ↗